Clinical Trials Logo

Arrhytmia in Psoriasis clinical trials

View clinical trials related to Arrhytmia in Psoriasis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02045485 Completed - Clinical trials for Arrhytmia in Psoriasis

P Wave and QT Dispersion in Psoriasis

Start date: January 2006
Phase: N/A
Study type: Observational [Patient Registry]

Background: Several reports have demonstrated an association between psoriasis and cardiovascular diseases. P wave dispersion (PWD) is the most important electrocardiographic (ECG) markers used to evaluate the risk of atrial arrhythmias. QT dispersion (QTD) can be used to assess homogeneity of cardiac repolarization and may be a risk for ventricular arrhythmias. Aim: To search PWD and QTD in patients with psoriasis. Methods: Ninety-four outpatient psoriasis patients and 51 healthy people were evaluated by physical examination, 12-lead ECG and transthoracic echocardiography. Severity of the psoriasis was evaluated by psoriasis Area and Severity Index (PASI).